Finance

Beta
Lists
TRIB:NASDAQ
Trinity Biotech PLC
$0.57
-15.83%
(-0.11) 1D
$0.59
+4.16% (+0.024)
Pre-market
Closed: Jun 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRIB...
Open
$0.74
High
$0.74
Low
$0.56
Mkt. cap
11.50M
Avg. vol.
129.35K
Volume
9.38K
52-wk high
$3.44
52-wk low
$0.51
EPS
-$2.01
Beta
0.92
Shares outstanding
20.25M
No. of employees
287
Open
$0.74
High
$0.74
Low
$0.56
Mkt. cap
11.50M
Avg. vol.
129.35K
Volume
9.38K
52-wk high
$3.44
52-wk low
$0.51
EPS
-$2.01
Beta
0.92
Shares outstanding
20.25M
No. of employees
287
News stories
From sources across the web
About Trinity Biotech PLC
CEO-
Employees287
Founded1992
Headquarters-
SectorMedical device
Websitetrinitybiotech.com
Last report
Apr 30, 2026
Fiscal period
Q4 2025
EPS / Est. (USD)
$0.35 / -$0.32
+209.37%beat
Revenue / Est. (USD)
12.69M / 15.00M
-15.39%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
7.57M
10.83M
14.31M
11.07M
Cost of goods sold
5.66M
6.22M
7.84M
7.17M
Cost of revenue
5.66M
6.22M
7.84M
7.17M
Research and development expenses
1.12M
638.00K
817.00K
1.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.52M
6.98M
6.19M
5.78M
Operating expense
6.64M
7.62M
6.98M
5.00M
Total operating expenses
12.30M
13.83M
14.82M
12.18M
Operating income
-4.73M
-3.00M
-509.00K
-1.10M
Other non operating income
630.00K
1.18M
-1.52M
474.00K
EBT including unusual items
-8.79M
-5.67M
-5.06M
-17.65M
EBT excluding unusual items
-7.04M
-5.13M
-5.36M
-3.89M
Income tax expense
6.00K
294.00K
73.00K
-174.00K
Effective tax rate
-0.07%
-5.18%
-1.44%
0.99%
Other operating expenses
-
-
-30.00K
-1.84M
Net income
-8.80M
-5.97M
-5.14M
-17.48M
Net profit margin
-116.21%
-55.09%
-35.88%
-157.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.94M
-3.31M
-3.33M
-3.26M
Net interest expenses
-2.94M
-3.31M
-3.33M
-3.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.09M
-2.35M
151.00K
-779.25K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer